المؤلفون: Thangaraju P; Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., Venkatesan S; Department of Clinical Division, Central Leprosy Teaching and Research Institute, Ministry of Health and Family Welfare, Chengalpattu, Tamilnadu, India., Sivashanmugam E; Department of Clinical Division, Central Leprosy Teaching and Research Institute, Ministry of Health and Family Welfare, Chengalpattu, Tamilnadu, India., Showkath Ali MK; Advisor, National Centre for Disease Control, Ministry of Health and Family Welfare, Calicut, Kerala, India.

المصدر: Indian journal of pharmacology [Indian J Pharmacol] 2019 Jan-Feb; Vol. 51 (1), pp. 72-74.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751 (Electronic) Linking ISSN: 02537613 NLM ISO Abbreviation: Indian J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Bradycardia/*chemically induced , Erythema Nodosum/*drug therapy , Leprostatic Agents/*adverse effects , Leprosy, Lepromatous/*drug therapy , Thalidomide/*adverse effects, Adult ; Dose-Response Relationship, Drug ; Humans ; Leprostatic Agents/administration & dosage ; Male ; Thalidomide/administration & dosage ; Young Adult